ISOTRETINOIN Mepha caps moll 20 mg 100 pce

7680559720159 CH-55972 D10BA01 10.02.0.

Reimbursement limitations:

TRETINAC

Formes graves de l'acné, résistantes à la thérapie.

ISOTRETINOIN Mepha caps moll 20 mg 100 pce
ISOTRETINOIN Mepha caps moll 20 mg 100 pce
ISOTRETINOIN Mepha caps moll 20 mg 100 pce
1 / 3
google

Details

Product number
5597202
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
isotretinoinum 20 mg, sojae oleum raffinatum 265.6 mg, int-rac-alpha-tocopherolum, dinatrii edetas corresp. natrium 0.12 mg, E 320, oleum vegetabile hydrogenatum, sojae oleum partim hydrogenatum 15.4 mg, cera flava, Kapselhülle: gelatina, glycerolum, sorbitolum liquidum non cristallisabile 16.98 mg, aqua purificata, E 124 336 µg, E 132, E 171, pro capsula.

Articles (1)

Isotretinoin-Mepha 20 mg, Weichkapseln
Weichkapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/08/2023
Patient information leaflet
Français
22/08/2023
Patient information leaflet
Italien
22/08/2023
Professional SmPC
Allemand
22/08/2023
Professional SmPC
Français
22/08/2023
Professional SmPC
Italien
22/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
265.6 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.12 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
15.4 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
16.98 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
336.0 UG Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 74.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2003

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
55972
Drug name
Isotretinoin-Mepha, Weichkapseln
Galenic form
KAPWE
ATC Code
D10BA01
Authorization status
Z
Dispensation category
A
First authorization
18/09/2002
Authorization expiration date
31/12/9999
IT number
10.02.0.
Domain
Human medicine
Field of application
Schwere therapieresistente Formen von Akne

Packaging details

Description (FR)
ISOTRETINOIN Mepha caps moll 20 mg 100 pce
Description (DE)
ISOTRETINOIN Mepha Weichkaps 20 mg 100 Stk
Market launch
18/09/2002
Narcotic (BTM)
No

Other packaging sizes

ISOTRETINOIN Mepha caps moll 10 mg 30 pce
30 KAP
GTIN: 7680559720098
View
ISOTRETINOIN Mepha caps moll 10 mg 100 pce
100 KAP
GTIN: 7680559720111
View
ISOTRETINOIN Mepha caps moll 20 mg 30 pce
30 KAP
GTIN: 7680559720135
View
ISOTRETINOIN Mepha caps moll 40 mg 30 pce
30 KAP
GTIN: 7680559720173
View
ISOTRETINOIN Mepha caps moll 40 mg 100 pce
100 KAP
GTIN: 7680559720197
View
ISOTRETINOIN Mepha caps moll 5 mg 30 pce
30 KAP
GTIN: 7680559720012
View
ISOTRETINOIN Mepha caps moll 5 mg 100 pce
100 KAP
GTIN: 7680559720029
View